SIGMA-ALDRICH search Sigma-Aldrich VEGFA products
includes other brands or spellings
|
| wb | | Sigma anti-VEGF antibody was used in human ovarian carcinoma cell lines and in western blot to study the role for endothelin-1-induced prostaglandin E2-EP2, EP4 signaling in regulating vascular endothelial growth factor production and ovarian carcinoma cell invasion. |
SANTA CRUZ BIOTECHNOLOGY search Santa Cruz Biotechnology VEGFA products
includes other brands or spellings
|
| block | | Santa Cruz anti-VEGF antibody was used in blocking or activating expriments to study the effect of M-CSF on VEGF production in human monocytes. |
| flow | | Santa Cruz goat polyclonal anti-VEGF antibody A-20 was used in PBMCs from human and in flow cytometry to study the effect of purified protein derivative of tuberculin on the expression of vascular endothelial growth factor in T lymphocytes in vitro. |
| ih | | Santa Cruz Biotechnology rabbit anti-VEGF antibody (sc-152) was used in immunohistochemistry to hypoxia-inducible factor 1 alpha and vascular endothelial growth factor overexpression in ischemic colitis. |
| ih | | Santa Cruz Biotechnology rabbit anti-VEGF antibody was used in immunohistochemistry to provide evidence that there is systemic production of VEGF and flt-1 in acute Kawasaki disease. |
| ih | | Santa Cruz Biotechnology rabbit polyclonal anti-VEGF antibody A-20 was used in paraffin sections from human primary sporadic colorectal adenocarcinomas and in immunohistochemistry to study the expression of iNOS and its activity in human colorectal tumors. |
| ih | | Santa Cruz Biotechnology rabbit anti-VEGF polyclonal antibody A-20 was used in immunohistochemistry to detect VEGF expression in human non–small-cell lung cancer (NSCLC). |
| ih | | Santa Cruz Biotechnology rabbit anti-human VEGF polyclonal antibody was used in immunohistochemistry to detect VEGF in morphologically normal human embryos. |
| ih | | Santa Cruz Biotechnology monoclonal anti-VEGF antibody (c-1) was used in paraffin sections from human tumor and in immunohistochemistry to study the value of the RECK and MMP-9 as prognostic indicator for colorectal cancer. |
| ih | | Santa Cruz Biotechnology monoclonal VEGF antibody was used in immunohistochemistry to study its expression in synovial tissues. |
| wb | | Santa Cruz VEGF antibody was used in western blot to characterize hepatoma-derived growth factor. |
| wb | | Santa Cruz Biotechnology anti-VEGF antibody was used in western blot to study the activity of matrix metalloproteinases to cleave connective tissue growth factor and reactivate angiogenic activity of vascular endothelial growth factor 165. |
| wb | | Santa Cruz Biotechnology anti-VEGF antibody was used in human endometrial adenocarcinoma HEC-1-B cells and in western blot to study the relative impact of fibroblast growth factor-2 (FGF-2) and vascular endothelial growth factor (VEGF) on tumor growth and neovascularization. |
| wb | | Santa Cruz Biotechnology rabbit anti-human VEGF antibody was used in western blot to study the angiogenic phenotype regulation by mitochondrial H2O2 via PTEN oxidation. |
| wb | | Santa Cruz Biotechnology anti-VEGF antibody was used in western blot to study the production of interleukin 15 by human colon cancer cells associated with induction of mucosal hyperplasia, angiogenesis, and metastasis. |
| wb | | Santa Cruz Biotechnology VEGF antibody was used in western blot to study the transcriptional stimulation in colon cancer by prostaglandin E2. |
R & D SYSTEMS search R & D Systems VEGFA products
includes other brands or spellings
|
| block | | R & D Systems mouse anti-human IgG2B VEGF monoclonal neutralizing antibody was used to the angiogenic phenotype regulation by mitochondrial H2O2 via PTEN oxidation. |
| elisa | | R&D Systems anti-VEGF antibody was used in ELISA to study the expression of macrophage migration inhibitory factor and CXC chemokine in non-small cell lung cancer. |
| elisa | | R&D Systems anti-VEGF antibody (VEGF glyceraldehyde-3-phosphate dehydrogenase Quantikine ELISA kit) was used in ELISA to study the expression of p68 DEAD box RNA helicase in keratinocytes. |
| elisa | | R&D System human immunoassay kit specific for the soluble isoforms VEGF121 and VEGF165 was used in ELISA to provide evidence that autocrine-paracrine VEGF loops may functionally operate in the maturation of megakaryocytic precursors through Flt1 receptor. |
| elisa | | R&D Systems anti-human VEGF antibody (which was in Quantikine human VEGF immunoassay kit) was used in human ovarian carcinoma cell lines and in ELISA to study the role for endothelin-1-induced prostaglandin E2-EP2, EP4 signaling in regulating vascular endothelial growth factor production and ovarian carcinoma cell invasion. |
| elisa | | R & D Systems VEGF antibody was used in ELISA to study the migratory-adhesive switch in Ewing's Sarcoma Cells triggered by matrix metalloproteinase-9 silencing. |
| elisa | | R&D Systems goat polyclonal anti-VEGF antibody (which was in ELISA kit) was used in PBMCs from human and in ELISA to study the effect of purified protein derivative of tuberculin on the expression of vascular endothelial growth factor in T lymphocytes in vitro. |
| elisa | | R&D Systems Quantikine human VEGF immunoassay kit was used to study the differing effect of HIF1 and HIF2 in von Hippel-Lindau-Associated renal cell carcinoma. |
| elisa | | R&D Systems goat polyclonal anti-human VEGF antibody was used in ELISA to study the HSulf-2 which selectively mobilizes heparin-bound growth factors and chemokines. |
| elisa | | R & D System VEGF enzyme-linked immunosorbent assay kit was used to study the transcriptional stimulation in colon cancer by prostaglandin E2. |
| ih | | R&D Systems mouse anti-human VEGF monoclonal antibody was used in immunohistochemistry to detect VEGF in HCC tumor section. |
| ih | | R&D Systems mouse monoclonal VEGF antibody was used in immunohistochemistry to study its expression in breast fibroepithelial tumors. |
| wb | | R&D Systems anti-VEGF antibody was used in western blot to study the relationship between FPR expression and the biologic behavior of glioma cells. |
EMD BIOSCIENCES search EMD Biosciences VEGFA products
includes other brands or spellings
|
| ih, wb | | Oncogene rabbit polyclonal anti-VEGF antibody was used in human MCF-7 cells and paraffin sections from human tumor, and which were respectively used in western blot and immunohistochemistry, to study the role for the effect of hypoxia on cross-talk between Syk and Lck in breast cancer progression and angiogenesis. |
| ih | | Oncogene Science polyclonal rabbit anti-serum against VEGF of human origin antibody Ab-2 (which recognizes an amino-terminal epitope found in VEGF121, 165, 189 and 206) was used in paraffin sections from human gastric precancerous and cancerous lesions and in immunohistochemistry to study the correlation of expression of p53, VEGF and iNOS and clinical features in gastric carcinogenesis. |
| ih | | Oncogene rabbit polyclonal anti-VEGF antibody (Ab-1) was used in paraffin sections from human breast cancer and in immunohistochemistry to study the correlation of ET axis expression with VEGF and angiogenesis in breast cancer. |
MILLIPORE search Millipore VEGFA products
includes other brands or spellings
|
| block | | Upstate Biotechnology mouse monoclonal anti-VEGF IgG was used in blocking experiment to study the activity of matrix metalloproteinases to cleave connective tissue growth factor and reactivate angiogenic activity of vascular endothelial growth factor 165. |
THERMO FISHER SCIENTIFIC search Thermo Fisher Scientific VEGFA products
includes other brands or spellings
|
| ih | | Neomarker mouse monoclonal anti-VEGF antibody Ab3 (which recognizes smaller isoform (VEGF121) of VEGF) was used in immunohistochemistry to study the expression of HIF-2a/EPAS1 in hepatocellular carcinoma. |
| wb | | Lab Vision VEGF Ab-3 antibody was tested in western blot by Abminer. |
BIOGENEX search Biogenex VEGFA products
includes other brands or spellings
|
| ih | | Biogenex polyclonal anti-VEGF antibody was used in immunohistochemistry to detect VEGF in tumor tissue from patients with breast cancer. |
MAXIN CO
|
| ih | | Maxin Co. anti-VEGF antibody was used in paraffin sections from human gastric carcinoma and in immunohistochemistry to study the relationship between the expression of inducible nitric oxide synthase (iNOS), vascular endothelial growth factor (VEGF), the microvascular density (MVD) and the pathological features and clinical staging of gastric cancer. |
Articles Reviewed |
| 1. Kumi Yasukawa et al. Systemic production of vascular endothelial growth factor and fms-like tyrosine kinase-1 receptor in acute Kawasaki disease. 2002 |
| 2. Wataru Matsuyama et al. Purified protein derivative of tuberculin upregulates the expression of vascular endothelial growth factor in T lymphocytes in vitro. 2002 |
| 3. Chang Wei Feng et al. Expression of p53, inducible nitric oxide synthase and vascular endothelial growth factor in gastric precancerous and cancerous lesions: correlation with clinical features. 2002 |
| 4. Gakuji Hashimoto et al. Matrix metalloproteinases cleave connective tissue growth factor and reactivate angiogenic activity of vascular endothelial growth factor 165. 2002 |
| 5. Zheng-Jun Song et al. Relationship between the expression of iNOS,VEGF,tumor angiogenesis and gastric cancer. 2002 |
| 6. Ida Casella et al. Autocrine-paracrine VEGF loops potentiate the maturation of megakaryocytic precursors through Flt1 receptor. 2003 |
| 7. Eric S White et al. Macrophage migration inhibitory factor and CXC chemokine expression in non-small cell lung cancer: role in angiogenesis and prognosis. 2003 |
| 8. Fabio Cianchi et al. Inducible nitric oxide synthase expression in human colorectal cancer: correlation with tumor angiogenesis. 2003 |
| 9. J Sato et al. Correlations of the expression of fibroblast growth factor-2, vascular endothelial growth factor, and their receptors with angiogenesis in synovial tissues from patients with internal derangement of the temporomandibular joint. 2003 |
| 10. Raffaella Giavazzi et al. Distinct role of fibroblast growth factor-2 and vascular endothelial growth factor on tumor growth and angiogenesis. 2003 |
| 11. Josiane Sancéau et al. Matrix metalloproteinase-9 silencing by RNA interference triggers the migratory-adhesive switch in Ewing's sarcoma cells. 2003 |
| 12. Tim D Eubank et al. M-CSF induces vascular endothelial growth factor production and angiogenic activity from human monocytes. 2003 |
| 13. Hiroki Kuniyasu et al. Production of interleukin 15 by human colon cancer cells is associated with induction of mucosal hyperplasia, angiogenesis, and metastasis. 2003 |
| 14. Anna Maria Granato et al. Basic fibroblast growth factor and vascular endothelial growth factor serum levels in breast cancer patients and healthy women: useful as diagnostic tools?. 2004 |
| 15. Karïn Gogat et al. VEGF and KDR gene expression during human embryonic and fetal eye development. 2004 |
| 16. Allen D Everett et al. Hepatoma-derived growth factor is a pulmonary endothelial cell-expressed angiogenic factor. 2004 |
| 17. Gassimou Bangoura et al. Expression of HIF-2alpha/EPAS1 in hepatocellular carcinoma. 2004 |
| 18. Pia Wülfing et al. Endothelin-1-, endothelin-A-, and endothelin-B-receptor expression is correlated with vascular endothelial growth factor expression and angiogenesis in breast cancer. 2004 |
| 19. Ronnie T Poon et al. Clinical significance of thrombospondin 1 expression in hepatocellular carcinoma. 2004 |
| 20. Kornelija Kahlina et al. p68 DEAD box RNA helicase expression in keratinocytes. Regulation, nucleolar localization, and functional connection to proliferation and vascular endothelial growth factor gene expression. 2004 |
| 21. Taku Takeuchi et al. The membrane-anchored matrix metalloproteinase (MMP) regulator RECK in combination with MMP-9 serves as an informative prognostic indicator for colorectal cancer. 2004 |
| 22. Francesca Spinella et al. Endothelin-1-induced prostaglandin E2-EP2, EP4 signaling regulates vascular endothelial growth factor production and ovarian carcinoma cell invasion. 2004 |
| 23. Shinya Ishikawa et al. Matrix metalloproteinase-2 status in stromal fibroblasts, not in tumor cells, is a significant prognostic factor in non-small-cell lung cancer. 2004 |
| 24. Kip M Connor et al. Mitochondrial H2O2 regulates the angiogenic phenotype via PTEN oxidation. 2005 |
| 25. Tomoyuki Okuda et al. Hypoxia-inducible factor 1 alpha and vascular endothelial growth factor overexpression in ischemic colitis. 2005 |
| 26. Jinyi Shao et al. Prostaglandin E2 Stimulates the beta-catenin/T cell factor-dependent transcription in colon cancer. 2005 |
| 27. Ye Zhou et al. Formylpeptide receptor FPR and the rapid growth of malignant human gliomas. 2005 |
| 28. Raju R Raval et al. Contrasting properties of hypoxia-inducible factor 1 (HIF-1) and HIF-2 in von Hippel-Lindau-associated renal cell carcinoma. 2005 |
| 29. Arno Kuijper et al. Expression of hypoxia-inducible factor 1 alpha and its downstream targets in fibroepithelial tumors of the breast. 2005 |
| 30. Kenji Uchimura et al. HSulf-2, an extracellular endoglucosamine-6-sulfatase, selectively mobilizes heparin-bound growth factors and chemokines: effects on VEGF, FGF-1, and SDF-1. 2006 |
| 31. Goutam Chakraborty et al. Hypoxia regulates cross-talk between Syk and Lck leading to breast cancer progression and angiogenesis. 2006 |
| 32. Sylvia M Major et al. AbMiner: a bioinformatic resource on available monoclonal antibodies and corresponding gene identifiers for genomic, proteomic, and immunologic studies. 2006 |